Yoh Zen

Yoh Zen

Auto-generated profile, based on publicly available information

Yoh Zen

Institute of Liver Studies King's College Hospital, King's College London London UK

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2015 in Medicine
Verified
Journal Article
Open access
DIDai Inoue
Dai Inoue
KYKotaro Yoshida
Kotaro Yoshida
NYNorihide Yoneda
Norihide Yoneda
KOKumi Ozaki
Kumi Ozaki
TMTakashi Matsubara
Takashi Matsubara
YZYoh Zen
Yoh Zen
Immunoglobulin G4-related disease (IgG4-RD) is a recently discovered systemic condition, in which various organ manifestations are linked by a similar histological appearance. Our knowledge of this condition is still fragmented, as most studies have examined only a few dozen patients or focused on a particular organ manifestation. This study was conducted to learn the demography and patient characteristics of IgG4-RD using a large cohort. A total of 235 consecutive patients with IgG4-RD, diagnosed in 8 general hospitals in the same medical district, were identified by searching the institutions' radiology database. Inclusion criteria were histology-proven IgG4-RD according to the Pathology Consensus Statement and/or definitive type 1 autoimmune pancreatitis meeting the International Consensus Diagnostic Criteria. Clinical notes and images of selected patients were retrospectively reviewed. All patients were adults (M/F = 4/1). The median age was 67 years (range 35-86). Nine tenths were diagnosed in their 50s to 70s. Among 486 manifestations identified in total, the most common was pancreatitis diagnosed in 142 patients (60%), followed by sialadenitis (34%), tubulointerstitial nephritis (23%), dacryoadenitis (23%), and periaortitis (20%). The majority of patients (95%) had at least 1 of the 5 most common manifestations. Male and female patients differed in their organ manifestations (periaortitis more common in males and sialodacryoadenitis more common in females). Serum IgG4 (normal ≤135 mg/dL) was elevated to >135 mg/dL in 208 patients (88%) and >270 mg/dL in 167 (71%). The IgG4 value was significantly higher in patients with multiorgan involvement than in those with a single manifestation (median 629 mg/dL vs 299 mg/dL, P < 0.01). Of 218 patients, for whom both IgG4 and IgG values were available, the IgG4/IgG ratio was raised to >10% in 194 (89%). Corticosteroids were effective, but the relapse rate was estimated to be 24% in the study period (median 37 months). During the follow-up, 15 malignant diseases were diagnosed in 13 patients (6%). This figure is similar to the incidence (12.9 cancers) expected from the Japanese nationwide study for cancer epidemiology (standardized incidence ratio 1.16). In conclusion, this reliable dataset could improve the characterization of IgG4-RD, particularly its unique demography and the frequency of each organ manifestation.


8 May 2023 in Journal of Hepatology
Verified
Journal Article
Open access
RARaul J. Andrade
Raul J. Andrade
GAGuruprasad Aithal
Guruprasad Aithal
NBNanne De Boer
Nanne De Boer
RLRodrigo Liberal
Rodrigo Liberal
Alexander GerbesAlexander Gerbes
Alexander Gerbes
EBEinar S. Björnsson
Einar S. Björnsson
Drug-induced liver injury (DILI) can mimic almost all other liver disorders. A phenotype increasingly ascribed to drugs is autoimmune-like hepatitis (ALH). This article summarises the major topics discussed at a joint International Conference held between the Drug-Induced Liver Injury consortium and the International Autoimmune Hepatitis Group. DI-ALH is a liver injury with laboratory and/or histological features that may be indistinguishable from those of autoimmune hepatitis (AIH). Previous studies have revealed that patients with DI-ALH and those with idiopathic AIH have very similar clinical, biochemical, immunological and histological features. Differentiating DI-ALH from AIH is important as patients with DI-ALH rarely require long-term immunosuppression and the condition often resolves spontaneously after withdrawal of the implicated drug, whereas patients with AIH mostly require long-term immunosuppression. Therefore, revision of the diagnosis on long-term follow-up may be necessary in some cases. More than 40 different drugs including nitrofurantoin, methyldopa, hydralazine, minocycline, infliximab, herbal and dietary supplements (such as Khat and Tinospora cordifolia) have been implicated in DI-ALH. Understanding of DI-ALH is limited by the lack of specific markers of the disease that could allow for a precise diagnosis, while there is similarly no single feature which is diagnostic of AIH. We propose a management algorithm for patients with liver injury and an autoimmune phenotype. There is an urgent need to prospectively evaluate patients with DI-ALH systematically to enable definitive characterisation of this condition.

24 September 2019 in Histopathology
Verified
Journal Article
Closed access
PDF file
YZYoh Zen
Yoh Zen
YCYen‐Ying Chen
Yen‐Ying Chen
YJYung‐Ming Jeng
Yung‐Ming Jeng
HTHung‐Wen Tsai
Hung‐Wen Tsai
MYMatthew M. Yeh
Matthew M. Yeh

27 January 2016 in Journal of Gastroenterology
Verified
Journal Article
Closed access
PDF file
YZYoh Zen
Yoh Zen
HKHiroshi Kawakami
Hiroshi Kawakami
JKJung Hoon Kim
Jung Hoon Kim

1 November 2019 in Seminars in Diagnostic Pathology
Verified
Journal Article
Closed access
YZYoh Zen
Yoh Zen
MYMatthew M. Yeh
Matthew M. Yeh